ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain

Neuropsychobiology

Volumn 35, Issue 2, 1997, Pages 73-78

  Volpi, R ^a   Caffarra, P ^a   Boni, S ^a   Scaglioni, A ^b   Malvezzi, L ^b   Saginario, A ^b   Chiodera, P ^a   Coiro, V ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Hospital of Fidenza   (Italy)

Author keywords

Adrenocorticotropic hormone; Cortisol; Fenfluramine; Parkinson s disease; Serotonergic system

Indexed keywords

CORTICOTROPIN; FENFLURAMINE; HYDROCORTISONE; SEROTONIN AGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

EID: 0030934217     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119394     Document Type: Article

References (30)

1. Polkovits M, Saavedra JM, Jacobowitz DM, Kiser JS, Zaborsky L, Brownstein MJ: Serotonergic innervation of the forebrain: Effect of lesions on serotonin and tryptophan hydroxylase levels. Brain Res 1977;130:121-134.
2. Van De Kar LD, Lorens LA: Differential serotonergic innervation of individual hypothalamic nuclei and other forebrain regions by the dorsal and median midbrain raphe nuclei. Brain Res 1979;162:45-54.
3. Bowker RM, Westlund KN, Sullivan MC, Wilber JF, Coulter JD: Descending serotonergic, peptidergic and cholinergic pathways from the raphe nuclei: A multiple transmitter complex. Brain Res 1983;288:33-48.
4. Steinbusch HW. Nieuwenhuys R: Distribution of serotonin-immunoreactivity in the central nervous system and pituitary of the rat with special references to the innervation of the hypothalamus. Adv Exp Med Biol 1981:133:7-35.
5. Van De Kar LD: Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu Rev Pharmacol Toxicol 1991;31:289-320.
6. Garattini S, Caccia S, Mcnnini T, Samamin R, II Consolo S, Ladinsky H: Biochemical pharmacology of the anorectic drug fenfluramine: A review. Curr Med Res Opin 1979;6(suppl 6): 1215-17.
7. Scatton B. Javoy-Agid F, Rouquier L, Dubois B, Agid Y: Reduction of cortical dopamine, serotonin and their metabolites in Parkinson’s disease. Brain Res 1983;275:321-328.
8. Tohgi H, Abe T, Takahashi S, Takahashi J. Hamato H: Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms. Neurosci Lett 1993; 150: 71-74.
9. Tohgi H, Abe T, Takahashi S, Takahashi J, Hamato H: Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson’s disease, and their changes after L-dopa 16 administration. Neurosci Lett 1993; 159:135-138.
10. Hoen HM, Yahr MD: Parkinsonism: Onset, progression and mortality. Neurology 1967; 17: 427-441.
11. Zigniond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
12. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 1978;35:773-782.
13. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960,23:56-62.
14. Coccaro EF, Sivier LJ, Klar HM, Maurer G, Cochrane K, Cooper TB. Mohs RC, Davis KL: Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive aggressive behaviour. Arch Gen Psychiatry 1989:46:587-599.
15. Javoy-Agid F, Ruberg L, Pique L, Bertagna X, Taquci H, Studler JM, Ccsselin F, Epelbaum J, Agid Y: Biochemistry of the hypothalamus in Parkinson’s disease. Neurology 1984:34:672-675.
16. Langston JS, Fomo LS: The hypothalamus in Parkinson’s disease. Ann Neurol 1978;3:129-133.
17. Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Homykiewiez O: Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: Observations in Parkinson's disease and normal subjects. Brain Res 1994:639:33-41.
18. Tuomisto J, Mannisto P: Neurotransmilter regulation of anterior pituitary hormones. Pharmacol Rev 1985;37:249-332.
19. Vermes I, Telegdy G, Lissak K: Correlation between hypothalamic serotonin content and adrenal function during acute stress, effect of adrenal corticosteroids on hypothalamic serotonin content. Acta Physiol Acad Sci Hung 1973;43:33-42.
20. Yehuda R, Meyer JS: A role for serotonin in the hypothalamic-pituitary-adrcnal response to insulin stress. Neuroendocrinology 1984;38:25-32.
21. Scapagnini U, Moberg GP, Van Loon GR, De Groot J, Ganong WF: Relation of brain 5-hydroxytryptamine to the diurnal variation in plasma corticosterone in the rat. Neuroendocrinology 1971;7:90-96.
22. Simon ML, George R: Diurnal variations in plasma corticosterone and growth hormone as correlated with regional variations in norepinephrine, dopamine and serotonin content of rat brain. Ncuroendocrinology 1975:17:125-138.
23. Allen-Rowlands CF, Allen JP, Greer MA. Wilson M: Circadian rhythmicity of ACTH and corticosterone in the rat. J Endocrinol Invest 1983;4:371-377.
24. Bellomo G, Santambrogio L, Fiacconi M, Scarponi AM, Ciuffetti G: Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolaetin in patients with untreated Parkinson’s disease. J Neurol 1991:238:19-22.
25. Muller EE, Nistico G, Scapagnini U: Neuro-transmitter and Anterior Pituitary Function. New York. Academic Press. 1977.
26. Weiner RI, Ganong WF: Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 1978:58:905-976.
27. Szafarezyk A, Ixart G, Malaval F, Nouguier-Soule J, Assenmacher I: Effects of lesions of the suprachiasmatic nuclei and of p-chlorophe-nylalaninc on the circadian rhythms of adrenocorticotropic hormone and corticosterone in the plasma and on locomotor activity of rats. J Endocrinol 1979;83:1-16.
28. Rosencrans JA: Effects of acute stress on forebrain 5-hydroxytryptamine metabolism and pituitary adrenal function. Eur J Pharmacol 1970;9:170-174.
29. Clemens J A, Bennet DR, Fuller RW: The effect of a tryptophan-free diet on prolactin and corticosterone release by serotonergic stimuli. Horm Metab Res 1980;12:35-38.
30. Micieli G, Martignoni E, Cavallini A, Sandrini G, Nappi G: Postprandial and orthostatic hypotension in Parkinson's disease. Neurology 1987;37:386-393.